La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Nanosonics Performance dei guadagni passati

Il passato criteri di controllo 5/6

Nanosonics ha registrato una crescita degli utili a un tasso medio annuo di 5.6%, mentre il settore Medical Equipment ha registrato utili in crescita a un tasso medio annuo di 5.6%. I ricavi sono stati in crescita a un tasso medio annuo di 15.9%. Il ritorno sul capitale proprio di Nanosonics è 8.9% e ha margini netti di 9.6%.

Informazioni chiave

5.6%

Tasso di crescita degli utili

5.5%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore	5.8%
Tasso di crescita dei ricavi	15.9%
Rendimento del capitale proprio	8.9%
Margine netto	9.6%
Prossimo aggiornamento sui guadagni	27 Aug 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

An Intrinsic Calculation For Nanosonics Limited (ASX:NAN) Suggests It's 21% Undervalued

Mar 30

Returns On Capital - An Important Metric For Nanosonics (ASX:NAN)

Mar 15

Time To Worry? Analysts Are Downgrading Their Nanosonics Limited (ASX:NAN) Outlook

Feb 28

Nanosonics Limited's (ASX:NAN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Feb 19

Is There Now An Opportunity In Nanosonics Limited (ASX:NAN)?

Feb 07

What Did Nanosonics' (ASX:NAN) CEO Take Home Last Year?

Jan 26

How Much Of Nanosonics Limited (ASX:NAN) Do Insiders Own?

Jan 14

Here's Why Nanosonics's (ASX:NAN) Statutory Earnings Are Arguably Too Conservative

Jan 01

Estimating The Intrinsic Value Of Nanosonics Limited (ASX:NAN)

Dec 20

Is There More Growth In Store For Nanosonics' (ASX:NAN) Returns On Capital?

Dec 07

Can You Imagine How Elated Nanosonics' (ASX:NAN) Shareholders Feel About Its 302% Share Price Gain?

Nov 25

Ripartizione dei ricavi e delle spese

Come Nanosonics guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

ASX:NAN Ricavi, spese e utili (AUD Millions )
Data	Ricavi	Guadagni	Spese G+A	Spese di R&S
31 Dec 23	164	16	88	32
30 Sep 23	165	18	87	31
30 Jun 23	166	20	85	29
31 Mar 23	154	15	81	27
31 Dec 22	141	10	77	25
30 Sep 22	131	7	73	24
30 Jun 22	120	4	68	22
31 Mar 22	120	7	64	21
31 Dec 21	121	11	60	20
30 Sep 21	112	10	57	19
30 Jun 21	103	9	54	17
31 Mar 21	99	7	51	17
31 Dec 20	95	6	49	16
30 Sep 20	97	8	48	16
30 Jun 20	100	10	48	16
31 Mar 20	96	11	47	14
31 Dec 19	92	12	46	13
30 Sep 19	88	13	42	12
30 Jun 19	84	14	38	11
31 Mar 19	78	12	36	11
31 Dec 18	71	11	34	11
30 Sep 18	66	8	33	10
30 Jun 18	61	6	33	10
31 Mar 18	61	6	31	10
31 Dec 17	61	6	29	10
30 Sep 17	64	16	28	10
30 Jun 17	68	26	28	9
31 Mar 17	65	26	26	9
31 Dec 16	63	25	25	8
30 Sep 16	53	13	25	8
30 Jun 16	43	0	25	7
31 Mar 16	33	-5	25	7
31 Dec 15	23	-10	24	6
30 Sep 15	23	-8	21	5
30 Jun 15	22	-5	18	5
31 Mar 15	24	-2	17	4
31 Dec 14	26	2	16	3
30 Sep 14	24	0	16	2
30 Jun 14	21	-3	17	1
31 Mar 14	21	-3	15	1
31 Dec 13	20	-3	14	1
30 Sep 13	18	-4	14	1

Guadagni di qualità: NAN ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di NAN (9.6%) NAN sono più alti rispetto allo scorso anno (7.2%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di NAN sono cresciuti del 5.6% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di NAN nell'ultimo anno ( 53.2% ) supera la media quinquennale ( 5.6% all'anno).

Guadagni vs Settore: La crescita degli utili NAN nell'ultimo anno ( 53.2% ) ha superato la percentuale del settore Medical Equipment 10.1%.

Nanosonics Performance dei guadagni passati

Il passato criteri di controllo 5/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

Nanosonics Limited to Report Fiscal Year 2024 Results on Aug 27, 2024

First half 2024 earnings released: EPS: AU$0.02 (vs AU$0.034 in 1H 2023)

Nanosonics Limited to Report First Half, 2024 Results on Feb 26, 2024

Full year 2023 earnings: EPS exceeds analyst expectations

Nanosonics Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

First half 2023 earnings: Revenues in line with analyst expectations

Recent updates

Nanosonics Limited to Report Fiscal Year 2024 Results on Aug 27, 2024

Independent Non-Executive Director recently sold AU$304k worth of stock

New minor risk - Insider selling

Key Executive recently bought AU$100k worth of stock

Returns On Capital At Nanosonics (ASX:NAN) Paint A Concerning Picture

First half 2024 earnings released: EPS: AU$0.02 (vs AU$0.034 in 1H 2023)

Some Confidence Is Lacking In Nanosonics Limited (ASX:NAN) As Shares Slide 33%

Now 37% undervalued after recent price drop

Consensus EPS estimates fall by 15%

Nanosonics Limited to Report First Half, 2024 Results on Feb 26, 2024

Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?

Now 20% undervalued after recent price drop

Investors Will Want Nanosonics' (ASX:NAN) Growth In ROCE To Persist

Now 20% undervalued after recent price drop

Nanosonics Limited Announces Appointment of Jason Burriss as Chief Financial Officer, Effective 3 October 2023

Consensus EPS estimates fall by 22%, revenue upgraded

Nanosonics Limited Appoints Larry Marshall as Non- Executive Director, Effective from 3 October 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Nanosonics Limited, Annual General Meeting, Nov 03, 2023

Nanosonics Limited to Report Fiscal Year 2023 Results on Aug 22, 2023

Nanosonics Limited Announces the Appointment of Tracey Batten as Non-Executive Director, Effective 26 September 2023

Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?

CEO, President recently sold AU$121k worth of stock

Nanosonics (ASX:NAN) Will Be Hoping To Turn Its Returns On Capital Around

Nanosonics Announces Company Secretary Changes

Independent Non-Executive Director recently sold AU$504k worth of stock

First half 2023 earnings: Revenues in line with analyst expectations

Consensus EPS estimates increase by 16%

Nanosonics Limited to Report First Half, 2023 Results on Feb 23, 2023

Consensus EPS estimates increase by 11%

Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?

Consensus EPS estimates increase by 25%

Insufficient new directors

Insufficient new directors

This Is Why Nanosonics Limited's (ASX:NAN) CEO Compensation Looks Appropriate

A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)

What Does Nanosonics Limited's (ASX:NAN) Share Price Indicate?

Now 20% undervalued

CEO, President recently sold AU$960k worth of stock

Consensus forecasts updated

Full year 2022 earnings: EPS exceeds analyst expectations

Nanosonics Limited, Annual General Meeting, Nov 18, 2022

Nanosonics Limited to Report Fiscal Year 2022 Results on Aug 23, 2022

Insufficient new directors

Consensus estimates of losses per share improve by 40%

Nanosonics Limited Provides Revenue Guidance for the Fiscal Year 2022

A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)

Now 21% undervalued after recent price drop

At AU$3.36, Is Nanosonics Limited (ASX:NAN) Worth Looking At Closely?

Nanosonics (ASX:NAN) Will Want To Turn Around Its Return Trends

Now 21% undervalued after recent price drop

Nanosonics Limited Announces Management Changes

Price target decreased to AU$4.79

A Look At The Intrinsic Value Of Nanosonics Limited (ASX:NAN)

Consensus EPS estimates have been downgraded.

First half 2022 earnings: EPS misses analyst expectations

Consensus revenue estimates fall by 11%

Nanosonics Limited to Report First Half, 2022 Results on Feb 22, 2022

Nanosonics Limited (ASX:NAN) Analysts Just Cut Their EPS Forecasts

Consensus EPS estimates fall by 46%

Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?

Nanosonics Limited's (ASX:NAN) CEO Looks Due For A Compensation Raise

Price target increased to AU$5.87

Nanosonics Limited Provides Earnings Guidance for the Fiscal Year 2022

Full year 2021 earnings released: EPS AU$0.029 (vs AU$0.034 in FY 2020)

Consensus forecasts updated

Returns Are Gaining Momentum At Nanosonics (ASX:NAN)

Consensus forecasts updated

Consensus forecasts updated